Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development program
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK
Gespeichert in:
| Veröffentlicht in: | Journal of the International AIDS Society 2010-11, Vol.13 (S4), p.O45-O45 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | O45 |
|---|---|
| container_issue | S4 |
| container_start_page | O45 |
| container_title | Journal of the International AIDS Society |
| container_volume | 13 |
| creator | Lazzarin, A Sierra‐Madero, JG Battegay, M Mukwaya, G Burnside, R Chapman, D McCracken, J Portsmouth, S Valluri, S Valdez, H Heera, J |
| description | 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK |
| doi_str_mv | 10.1186/1758-2652-13-S4-O45 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3112860</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A723607024</galeid><sourcerecordid>A723607024</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4425-ff552450cce72e3c35d0ac31003b0bb82d34a0d998eaca14e5c18bd373bf79403</originalsourceid><addsrcrecordid>eNqNks1u1DAQxyMEEqXwBFwsIfGhKuCvOEkPSKuFQlGrHgpcLceZZF059mIni3rjEXhGngSHrUoXUcTJo5nf_Gf8t7PsMcEvCanEK1IWVU5FQXPC8nOen_HiTrZ3nb17I76fPYjxAmNBK17vZeZUBbUxwWv0_PTz8gUyTgdQESJavuEHSLk2BdUB0mBtPETWu_7Ht-8jhAG1alSoC35A4wpQ6kbaGme0sqiFDVi_HsCNaB18H9TwMLvXKRvh0dW5n306evtx-T4_OXt3vFyc5A3ntMi7rigoL7DWUFJgmhUtVpoRjFmDm6aiLeMKt3VdgdKKcCg0qZqWlazpyppjtp-93uqup2aAVqcVgrJyHcygwqX0ysjdijMr2fuNZITQSswCR1uBxvhbBHYr2g9y9lfO_krC5DmX6QWS0LOrTYL_MkEc5WDi7KNy4Kcoq4phKriYySd_kBd-Ci7ZJBkWpSCCFPxfFKV1TXgiy99UryxI4zqfltTzZLkoKRO4xHTWyv9C9eAg3cg76ExK7_BPb_ArUHZcRW-n0XgXd0G2BXXwMQboro0jWM6f9Rar6m3X1zT38n9a5IfjBf3V-xNrQet0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2299146767</pqid></control><display><type>article</type><title>Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development program</title><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Lazzarin, A ; Sierra‐Madero, JG ; Battegay, M ; Mukwaya, G ; Burnside, R ; Chapman, D ; McCracken, J ; Portsmouth, S ; Valluri, S ; Valdez, H ; Heera, J</creator><creatorcontrib>Lazzarin, A ; Sierra‐Madero, JG ; Battegay, M ; Mukwaya, G ; Burnside, R ; Chapman, D ; McCracken, J ; Portsmouth, S ; Valluri, S ; Valdez, H ; Heera, J</creatorcontrib><description>7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1186/1758-2652-13-S4-O45</identifier><language>eng</language><publisher>Geneva: The International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; AIDS ; CD4 antigen ; CD4 lymphocytes ; CD8 lymphocytes ; Drug therapy ; Dyspnea ; Health aspects ; HIV ; HIV infection ; Human immunodeficiency virus ; Maraviroc ; Oral Presentation ; Smoking ; Testing</subject><ispartof>Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.O45-O45</ispartof><rights>2010 Lazzarin A et al; licensee International AIDS Society</rights><rights>COPYRIGHT 2010 John Wiley & Sons, Inc.</rights><rights>2010. This work is published under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright ©2010 Heera et al; licensee BioMed Central Ltd. 2010 Heera et al; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112860/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112860/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,1417,11562,27924,27925,45574,45575,46052,46476,53791,53793</link.rule.ids></links><search><creatorcontrib>Lazzarin, A</creatorcontrib><creatorcontrib>Sierra‐Madero, JG</creatorcontrib><creatorcontrib>Battegay, M</creatorcontrib><creatorcontrib>Mukwaya, G</creatorcontrib><creatorcontrib>Burnside, R</creatorcontrib><creatorcontrib>Chapman, D</creatorcontrib><creatorcontrib>McCracken, J</creatorcontrib><creatorcontrib>Portsmouth, S</creatorcontrib><creatorcontrib>Valluri, S</creatorcontrib><creatorcontrib>Valdez, H</creatorcontrib><creatorcontrib>Heera, J</creatorcontrib><title>Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development program</title><title>Journal of the International AIDS Society</title><description>7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK</description><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>CD4 antigen</subject><subject>CD4 lymphocytes</subject><subject>CD8 lymphocytes</subject><subject>Drug therapy</subject><subject>Dyspnea</subject><subject>Health aspects</subject><subject>HIV</subject><subject>HIV infection</subject><subject>Human immunodeficiency virus</subject><subject>Maraviroc</subject><subject>Oral Presentation</subject><subject>Smoking</subject><subject>Testing</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNqNks1u1DAQxyMEEqXwBFwsIfGhKuCvOEkPSKuFQlGrHgpcLceZZF059mIni3rjEXhGngSHrUoXUcTJo5nf_Gf8t7PsMcEvCanEK1IWVU5FQXPC8nOen_HiTrZ3nb17I76fPYjxAmNBK17vZeZUBbUxwWv0_PTz8gUyTgdQESJavuEHSLk2BdUB0mBtPETWu_7Ht-8jhAG1alSoC35A4wpQ6kbaGme0sqiFDVi_HsCNaB18H9TwMLvXKRvh0dW5n306evtx-T4_OXt3vFyc5A3ntMi7rigoL7DWUFJgmhUtVpoRjFmDm6aiLeMKt3VdgdKKcCg0qZqWlazpyppjtp-93uqup2aAVqcVgrJyHcygwqX0ysjdijMr2fuNZITQSswCR1uBxvhbBHYr2g9y9lfO_krC5DmX6QWS0LOrTYL_MkEc5WDi7KNy4Kcoq4phKriYySd_kBd-Ci7ZJBkWpSCCFPxfFKV1TXgiy99UryxI4zqfltTzZLkoKRO4xHTWyv9C9eAg3cg76ExK7_BPb_ArUHZcRW-n0XgXd0G2BXXwMQboro0jWM6f9Rar6m3X1zT38n9a5IfjBf3V-xNrQet0</recordid><startdate>201011</startdate><enddate>201011</enddate><creator>Lazzarin, A</creator><creator>Sierra‐Madero, JG</creator><creator>Battegay, M</creator><creator>Mukwaya, G</creator><creator>Burnside, R</creator><creator>Chapman, D</creator><creator>McCracken, J</creator><creator>Portsmouth, S</creator><creator>Valluri, S</creator><creator>Valdez, H</creator><creator>Heera, J</creator><general>The International AIDS Society</general><general>John Wiley & Sons, Inc</general><general>BioMed Central Ltd</general><scope>24P</scope><scope>WIN</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>201011</creationdate><title>Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development program</title><author>Lazzarin, A ; Sierra‐Madero, JG ; Battegay, M ; Mukwaya, G ; Burnside, R ; Chapman, D ; McCracken, J ; Portsmouth, S ; Valluri, S ; Valdez, H ; Heera, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4425-ff552450cce72e3c35d0ac31003b0bb82d34a0d998eaca14e5c18bd373bf79403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>CD4 antigen</topic><topic>CD4 lymphocytes</topic><topic>CD8 lymphocytes</topic><topic>Drug therapy</topic><topic>Dyspnea</topic><topic>Health aspects</topic><topic>HIV</topic><topic>HIV infection</topic><topic>Human immunodeficiency virus</topic><topic>Maraviroc</topic><topic>Oral Presentation</topic><topic>Smoking</topic><topic>Testing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lazzarin, A</creatorcontrib><creatorcontrib>Sierra‐Madero, JG</creatorcontrib><creatorcontrib>Battegay, M</creatorcontrib><creatorcontrib>Mukwaya, G</creatorcontrib><creatorcontrib>Burnside, R</creatorcontrib><creatorcontrib>Chapman, D</creatorcontrib><creatorcontrib>McCracken, J</creatorcontrib><creatorcontrib>Portsmouth, S</creatorcontrib><creatorcontrib>Valluri, S</creatorcontrib><creatorcontrib>Valdez, H</creatorcontrib><creatorcontrib>Heera, J</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lazzarin, A</au><au>Sierra‐Madero, JG</au><au>Battegay, M</au><au>Mukwaya, G</au><au>Burnside, R</au><au>Chapman, D</au><au>McCracken, J</au><au>Portsmouth, S</au><au>Valluri, S</au><au>Valdez, H</au><au>Heera, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development program</atitle><jtitle>Journal of the International AIDS Society</jtitle><date>2010-11</date><risdate>2010</risdate><volume>13</volume><issue>S4</issue><spage>O45</spage><epage>O45</epage><pages>O45-O45</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK</abstract><cop>Geneva</cop><pub>The International AIDS Society</pub><doi>10.1186/1758-2652-13-S4-O45</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1758-2652 |
| ispartof | Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.O45-O45 |
| issn | 1758-2652 1758-2652 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3112860 |
| source | DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Access via Wiley Online Library; Wiley Online Library Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Acquired immune deficiency syndrome AIDS CD4 antigen CD4 lymphocytes CD8 lymphocytes Drug therapy Dyspnea Health aspects HIV HIV infection Human immunodeficiency virus Maraviroc Oral Presentation Smoking Testing |
| title | Maraviroc (MVC) increases CD4+ and CD8+ cells: long‐term data from the MVC clinical development program |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T20%3A02%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Maraviroc%20(MVC)%20increases%20CD4+%20and%20CD8+%20cells:%20long%E2%80%90term%20data%20from%20the%20MVC%20clinical%20development%20program&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Lazzarin,%20A&rft.date=2010-11&rft.volume=13&rft.issue=S4&rft.spage=O45&rft.epage=O45&rft.pages=O45-O45&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1186/1758-2652-13-S4-O45&rft_dat=%3Cgale_pubme%3EA723607024%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2299146767&rft_id=info:pmid/&rft_galeid=A723607024&rfr_iscdi=true |